Table 4.

Summary of recommendations for parameters to be reported

Parameter(s)	Recommendation, diagnostic tracers	Recommendation, therapies
Absorbed dose for all source tissues and WB	Should be reported as population summary statistics including mean, standard deviation and range AND Should be reported for individual subjects including activity measurements at each time point, TAC parameters, and potentially volumes	Should be reported as population summary statistics including mean, standard deviation and range AND Should be reported for individual subjects including activity measurements at each time point, TAC parameters, and volumes
Absorbed doses to target tissues representing a complete set of human organs	Should be reported as summary statistics and for individual subjects	Should be reported as summary statistics and for individual subjects
Equivalent dose and effective dose	Should be reported using population data and most recent radiation and tissue weighting factors If deemed relevant can also be reported using older sets of weighting factors	Non-sensical
Dose parameters for tumours or other regions of disease	Not relevant	Should be reported for individual regions, and as summary statistics for tumour type. Should include activity measurements at each time point, TAC parameters, and volumes
Dose parameters for organ sub-structures	Not relevant	If deemed relevant, to include activity measurements at each time point, TAC parameters, and potentially also volumes
Relative biological effectiveness (RBE) weighted absorbed doses for source tissues and/or regions of disease	Non-sensical	Optional (only for alpha- or auger-emitters)
Biological effective doses (BEDs) for source tissues and/or regions of disease	Non-sensical	Encouraged, reported for each individual and as summary statistics
Voxel-dose-maps, including volume cut-offs (such as D90% or D98%) for summary statistics	Not relevant	If deemed relevant